Skip to main content
. 2024 Mar 28;74(741):e219–e226. doi: 10.3399/BJGP.2023.0328

Table 2.

Incidence of new cardiovascular events and death at 9 years’ follow-up

Cardiovascular event and death Total, n (%), n = 530 Male, n (%), n = 229 Female, n (%), n = 301 P-value
Coronary event 31 (5.8) 15 (6.6) 16 (5.3) 0.549
Myocardial infarction 9 (1.7) 2 (0.9) 7 (2.3) 0.200
Unstable angina pectoris 22 (4.2) 13 (5.7) 9 (3.0) 0.125

Cerebrovascular disease 44 (8.3) 20 (8.7) 24 (8.0) 0.753
TIA 22 (4.2) 9 (3.9) 13 (4.3) 0.824
Stroke 24 (4.5) 11 (4.8) 13 (4.3) 0.790

Atrial fibrillation 53 (10.0) 28 (12.2) 25 (8.3) 0.136

Heart failure 23 (4.3) 8 (3.5) 15 (5.0) 0.404

All-cause mortality 66 (12.5) 32 (14.0) 34 (11.3) 0.355

CVE, 1 126 (23.8) 58 (25.3) 68 (22.6) 0.464

CVE, >1 27 (5.1) 14 (6.1) 13 (4.3) 0.352

CVE = cardiovascular event. TIA = transient ischaemic attack.